Literature DB >> 17051368

Cytogenetically balanced translocations are associated with focal copy number alterations.

Spencer K Watson1, Ronald J deLeeuw, Doug E Horsman, Jeremy A Squire, Wan L Lam.   

Abstract

Current cytogenetic methods (e.g., G-banding and multicolor chromosomal painting) allow detection of translocation events but lack the resolution to (a) locate the breakpoints precisely at the chromosome band level or (b) discriminate balanced translocations from translocations with copy number alterations not previously reported, or imperfectly balanced translocations. In this study, we demonstrate that cytogenetically balanced translocations are in fact frequently associated with segmental gain or loss of DNA. The recent development of a whole genome tiling path BAC array has enabled tiling resolution analysis of genomic segmental copy number status. Combining tiling resolution BAC array comparative genomic hybridization (array CGH) with G-Banding analysis and multicolor chromosomal painting approaches such as spectral karyotyping (SKY) facilitates high-resolution mapping of genomic alterations associated with imperfectly balanced translocations. Using a refined version of our CGH array we have deduced the copy number status throughout the genomes of three cytogenetically well-characterized prostate cancer cell lines (PC3, DU145, LNCaP) to determine whether translocations are associated with focal gains and losses of DNA. At 78 kb tiling resolution we identified the boundaries of 170, 80, and 34 known and novel copy number alterations (CNA) in these cell line genomes, respectively. Thirty-three of the 36 known translocations (92%, P < 0.001) in DU145 were associated with segmental CNA. Likewise, 80% (P < 0.001) of the known translocations showed association in LNCaP. Although many translocation breakpoints exhibit segmental alteration in PC3, the pattern of chromosomal rearrangements is too complex for use in comprehensive association with CNA boundaries. Our results reveal that imperfectly balanced translocations in tumor genomes are a phenomenon that occurs at frequencies much higher than previously demonstrated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17051368     DOI: 10.1007/s00439-006-0251-9

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  32 in total

1.  Evidence of chromosomal instability in prostate cancer determined by spectral karyotyping (SKY) and interphase fish analysis.

Authors:  B Beheshti; P C Park; J M Sweet; J Trachtenberg; M A Jewett; J A Squire
Journal:  Neoplasia       Date:  2001 Jan-Feb       Impact factor: 5.715

2.  Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell lines.

Authors:  Karin G Hermans; Dirk C van Alewijk; Joris A Veltman; Wytske van Weerden; Ad Geurts van Kessel; Jan Trapman
Journal:  Genes Chromosomes Cancer       Date:  2004-03       Impact factor: 5.006

3.  Multiple microalterations detected at high frequency in oral cancer.

Authors:  Corisande Baldwin; Cathie Garnis; Lewei Zhang; Miriam P Rosin; Wan L Lam
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

Review 4.  Primary cell cultures as models of prostate cancer development.

Authors:  D M Peehl
Journal:  Endocr Relat Cancer       Date:  2005-03       Impact factor: 5.678

5.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.

Authors:  P A Steck; M A Pershouse; S A Jasser; W K Yung; H Lin; A H Ligon; L A Langford; M L Baumgard; T Hattier; T Davis; C Frye; R Hu; B Swedlund; D H Teng; S V Tavtigian
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

6.  High-resolution cDNA microarray CGH mapping of genomic imbalances in osteosarcoma using formalin-fixed paraffin-embedded tissue.

Authors:  M Zielenska; P Marrano; P Thorner; J Pei; B Beheshti; M Ho; J Bayani; Y Liu; B C Sun; J A Squire; X-S Hao
Journal:  Cytogenet Genome Res       Date:  2004       Impact factor: 1.636

7.  Use of whole genome amplification and comparative genomic hybridisation to detect chromosomal copy number alterations in cell line material and tumour tissue.

Authors:  S Hughes; G Lim; B Beheshti; J Bayani; P Marrano; A Huang; J A Squire
Journal:  Cytogenet Genome Res       Date:  2004       Impact factor: 1.636

8.  Reciprocal translocations: a trap for cytogenetists?

Authors:  Roberto Ciccone; Roberto Giorda; Giuliana Gregato; Renzo Guerrini; Sabrina Giglio; Romeo Carrozzo; Maria Clara Bonaglia; Emanuela Priolo; Carmelo Laganà; Romano Tenconi; Mariano Rocchi; Tiziano Pramparo; Orsetta Zuffardi; Elena Rossi
Journal:  Hum Genet       Date:  2005-07-23       Impact factor: 4.132

9.  Twinkle helicase is essential for mtDNA maintenance and regulates mtDNA copy number.

Authors:  Henna Tyynismaa; Hiroshi Sembongi; Monika Bokori-Brown; Caroline Granycome; Neil Ashley; Joanna Poulton; Anu Jalanko; Johannes N Spelbrink; Ian J Holt; Anu Suomalainen
Journal:  Hum Mol Genet       Date:  2004-10-27       Impact factor: 6.150

10.  SeeGH--a software tool for visualization of whole genome array comparative genomic hybridization data.

Authors:  Bryan Chi; Ronald J DeLeeuw; Bradley P Coe; Calum MacAulay; Wan L Lam
Journal:  BMC Bioinformatics       Date:  2004-02-09       Impact factor: 3.169

View more
  23 in total

1.  Array comparative genomic hybridization detects chromosomal abnormalities in hematological cancers that are not detected by conventional cytogenetics.

Authors:  Lina Shao; Sung-Hae L Kang; Jian Li; Patricia Hixson; Jesalyn Taylor; Svetlana A Yatsenko; Chad A Shaw; Aleksandar Milosavljevic; Chung-Che Chang; Sau Wai Cheung; Ankita Patel
Journal:  J Mol Diagn       Date:  2010-08-19       Impact factor: 5.568

Review 2.  Emerging technologies in paediatric leukaemia.

Authors:  Amanda Dixon-McIver
Journal:  Transl Pediatr       Date:  2015-04

3.  The identification of chromosomal translocation, t(4;6)(q22;q15), in prostate cancer.

Authors:  L Shan; L Ambroisine; J Clark; R J Yáñez-Muñoz; G Fisher; S C Kudahetti; J Yang; S Kia; X Mao; A Fletcher; P Flohr; S Edwards; G Attard; J De-Bono; B D Young; C S Foster; V Reuter; H Moller; T D Oliver; D M Berney; P Scardino; J Cuzick; C S Cooper; Y-J Lu
Journal:  Prostate Cancer Prostatic Dis       Date:  2010-02-23       Impact factor: 5.554

4.  The finding of a reciprocal whole-arm translocation t(X;12)(p10;p10) in association with atypical chronic myeloid leukaemia.

Authors:  P T Elder; M F McMullin; M W Humphreys; J Hamilton; P McGrattan
Journal:  Med Oncol       Date:  2009-08-06       Impact factor: 3.064

Review 5.  Genetic tests to evaluate prognosis and predict therapeutic response in acute myeloid leukemia.

Authors:  Margaret L Gulley; Thomas C Shea; Yuri Fedoriw
Journal:  J Mol Diagn       Date:  2009-12-03       Impact factor: 5.568

6.  Homozygous deletions and recurrent amplifications implicate new genes involved in prostate cancer.

Authors:  Wennuan Liu; Chunmei Carol Xie; Yi Zhu; Tao Li; Jishan Sun; Yu Cheng; Charles M Ewing; Sue Dalrymple; Aubrey R Turner; Jielin Sun; John T Isaacs; Bao-Li Chang; Siqun Lilly Zheng; William B Isaacs; Jianfeng Xu
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

7.  Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma.

Authors:  William W Lockwood; Raj Chari; Bradley P Coe; Kelsie L Thu; Cathie Garnis; Chad A Malloff; Jennifer Campbell; Ariane C Williams; Dorothy Hwang; Chang-Qi Zhu; Timon P H Buys; John Yee; John C English; Calum Macaulay; Ming-Sound Tsao; Adi F Gazdar; John D Minna; Stephen Lam; Wan L Lam
Journal:  PLoS Med       Date:  2010-07-27       Impact factor: 11.069

Review 8.  Cancer gene discovery in mouse and man.

Authors:  Jenny Mattison; Louise van der Weyden; Tim Hubbard; David J Adams
Journal:  Biochim Biophys Acta       Date:  2009-03-12

9.  Genomic imbalances in precancerous tissues signal oral cancer risk.

Authors:  Cathie Garnis; Raj Chari; Timon P H Buys; Lewei Zhang; Raymond T Ng; Miriam P Rosin; Wan L Lam
Journal:  Mol Cancer       Date:  2009-07-23       Impact factor: 27.401

10.  Transcriptome profiles of carcinoma-in-situ and invasive non-small cell lung cancer as revealed by SAGE.

Authors:  Kim M Lonergan; Raj Chari; Bradley P Coe; Ian M Wilson; Ming-Sound Tsao; Raymond T Ng; Calum Macaulay; Stephen Lam; Wan L Lam
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.